![Joseph Gilliam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Gilliam
Präsident bei GLAUKOS CORPORATION
Vermögen: 15 Mio $ am 31.12.2024
Profil
Joseph E.
Gilliam's current jobs include being a Director at Avedro, Inc. since 2019, a Director at Caris Life Sciences, LLC since 2021, and the President & Chief Operating Officer at Glaukos Corp.
since 2017.
Previously, he worked as a Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2001 to 2017.
He completed his undergraduate degree at Kelley School of Business in 1998.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLAUKOS CORP
0,18% | 30.12.2024 | 101 205 ( 0,18% ) | 15 Mio $ | 31.12.2024 |
Aktuelle Nachrichten zu Joseph Gilliam
Aktive Positionen von Joseph Gilliam
| Unternehmen | Position | Beginn |
|---|---|---|
| GLAUKOS CORPORATION | Präsident | 01.04.2022 |
| AVEDRO, INC. | Direktor/Vorstandsmitglied | 21.11.2019 |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Direktor/Vorstandsmitglied | 12.04.2021 |
Ehemalige bekannte Positionen von Joseph Gilliam
| Unternehmen | Position | Ende |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01.05.2017 |
Ausbildung von Joseph Gilliam
| Kelley School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| JPMORGAN CHASE & CO. | Finance |
| Private Unternehmen | 2 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Health Services |
